Atrial fibrillation post-cardiac surgery: changing perspectives.

Area of Science:

• Cardiology
• Cardiac Surgery
• Pharmacology

Background:

• Perioperative atrial fibrillation (AF) is a frequent complication following cardiac surgery.
• Postoperative AF is linked to increased morbidity, mortality, and healthcare costs.
• Established prophylactic strategies are crucial for managing this complication.

Purpose of the Study:

• To review current pharmacologic strategies for preventing and treating perioperative atrial fibrillation after cardiac surgery.
• To highlight evolving management perspectives for postoperative AF.

Main Methods:

• Literature review of prophylactic pharmacologic strategies for perioperative AF.
• Discussion of established and emerging treatments, including beta-blockers, calcium antagonists, amiodarone, sotalol, magnesium, statins, and n-3 polyunsaturated fatty acids.

Main Results:

• Beta-blockers, amiodarone, sotalol, and rate-limiting calcium antagonists are recommended for AF prophylaxis.
• Continuation of pre-existing beta-blocker therapy is advised unless contraindicated.
• Rhythm control is the recommended initial treatment for established postoperative AF.

Conclusions:

• Effective management of perioperative AF involves prophylactic pharmacologic strategies and appropriate treatment.
• Emerging therapies like magnesium, statins, and n-3 polyunsaturated fatty acids show potential in reducing AF incidence.
• Management approaches for postoperative AF are evolving, emphasizing proactive prevention and tailored treatment.